Is B-type natriuretic peptide a risk factor for heart failure in patients treated with bardoxolone methyl?

Letter to the Editor, comment on article entitled "Risk Factors for Heart Failure in Patients With Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated With Bardoxolone Methyl" by Chin et al in the Journal of Cardiac Failure. Disciplines Medicine and Health Sciences Publication Details Camer, D. & Huang, X. (2015). Is B-type natriuretic peptide a risk factor for heart failure in patients treated with bardoxolone methyl?. Journal of Cardiac Failure, 21 (3), 258-259. This journal article is available at Research Online: http://ro.uow.edu.au/ihmri/513 Comment on: Risk Factors for Heart Failure in Patients with Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated with Bardoxolone Methyl Authors: Danielle Camer and Xu-Feng Huang Affiliation: School of Medicine and Illawarra Health and Medical Research Institute, University of Wollongong, NSW, 2522, Australia. *Corresponding author: Professor Xu-Feng Huang, MD, PhD, DSc Illawarra Health and Medical Research Institute, School of Medicine, University of Wollongong, Northfields Avenue, NSW, 2522, Australia Tel.: 61-02-42214300 Fax: 61-02-42214096 E-mail address: [email protected]